Core Points - Fortrea has granted employment inducement awards to Anshul Thakral, the newly appointed President and CEO, effective August 4, 2025 [1] - The awards include 1,250,000 performance share units (PSUs) and 1,250,000 restricted stock units (RSUs), with specific vesting conditions [2] - The grants were made under the Company's 2025 Inducement Award Plan and comply with Nasdaq Listing Rules [3] Company Overview - Fortrea is a leading global provider of clinical development solutions for the life sciences industry, partnering with biopharmaceutical, biotechnology, medical device, and diagnostic companies [4] - The company offers phase I-IV clinical trial management, clinical pharmacology, and consulting services, leveraging over 30 years of experience across more than 20 therapeutic areas [4] - Fortrea operates in approximately 100 countries, providing agile solutions to its global customers [4]
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)